Abstract:Background: Glaucoma, the leading cause of irreversible blindness worldwide, is a type of retinal disease characterized by the selective death of retinal ganglion cells (RGCs). However, the pathogenesis of glaucoma has not been fully elucidated. Transient receptor potential vanilloid 4 (TRPV4) is a pressure-sensitive and calcium-permeable cation channel. TRPV4 is widely distributed in the retina and its sustained activation leads to RGC death; indicating that TRPV4 may be a possible target for glaucoma treatment. Here, we investigated the effects of TRPV4 on RGC apoptosis in a rat model of chronic ocular hypertension (COH), then examined the mechanism underlying these effects. Methods: The COH model was established by injection of micro-magnetic beads into the anterior chamber of adult male rats. The expression levels of TRPV4, glial fibrillary acidic protein, and inflammatory factors were assessed by immunohistochemistry and immunoblotting. RGC apoptosis and visual dysfunction were evaluated by TUNEL assay and photopic negative response. Functional expression of TRPV4 was examined by electrophysiology and calcium imaging. Real-time polymerase chain reaction and immunoblotting were employed to investigate the molecular mechanism underlying the effects of TRPV4 on tumor necrosis factor-α (TNF-α) release. Results: We found that TRPV4 played an essential role in glaucoma, such that high levels of TRPV4 expression were associated with elevated intraocular pressure. Furthermore, TRPV4 activation was involved in glaucoma-induced RGC apoptosis and RGC-related reductions in visual function. Mechanistic investigation demonstrated that TRPV4 activation led to enhanced Müller cell gliosis and TNF-α release via the JAK2/STAT3/NF-kB pathway, while TRPV4 inhibition could reverse these effects. Finally, TRPV4 activation could lead to elevated expression of TNF receptor 1 in RGCs, while inhibition of TNF-α could reduce TRPV4-mediated RGC apoptosis. Conclusions: TRPV4 activation induces Müller cell gliosis and TNF-α elevation via the JAK2/STAT3/NF-κB pathway, which may exacerbate RGC apoptosis in glaucoma; these results suggest that TRPV4 can serve as a therapeutic target in glaucoma treatment.

Role of Mammalian Target of Rapamycin in Regulating HIF-1α and Vascular Endothelial Growth Factor Signals in Glaucoma.

Blocking Mammalian Target of Rapamycin (mTOR) Attenuates HIF-1α Pathways Engaged-Vascular Endothelial Growth Factor (VEGF) in Diabetic Retinopathy

Topical administration of rapamycin promotes retinal ganglion cell survival and reduces intraocular pressure in a rat glaucoma model

Hyperglycemia-induced VEGF and ROS production in retinal cells is inhibited by the mTOR inhibitor, rapamycin

Rho/Rho-associated Kinase Pathway in Glaucoma (Review).

Mtor Signaling Pathway Regulates HIF-1α and VEGF

Abnormal Mtorc1 Signaling Leads to Retinal Pigment Epithelium Degeneration.

Rapamycin Mediates Mtor Signaling in Reactive Astrocytes and Reduces Retinal Ganglion Cell Loss

TRPV4-induced Müller cell gliosis and TNF-α elevation-mediated retinal ganglion cell apoptosis in glaucomatous rats via JAK2/STAT3/NF-κB pathway

Rac1 Conditional Deletion Attenuates Retinal Ganglion Cell Apoptosis by Accelerating Autophagic Flux in a Mouse Model of Chronic Ocular Hypertension.

Long-term HIF-1α stabilization reduces respiration, promotes mitophagy, and results in retinal cell death

Pathologically High Intraocular Pressure Induces Mitochondrial Dysfunction Through Drp1 and Leads to Retinal Ganglion Cell PANoptosis in Glaucoma

Translocator Protein 18 Kda Regulates Retinal Neuron Apoptosis and Pyroptosis in Glaucoma.

Rapamycin Attenuates Retinal Ganglion Cell Death by Inhibiting Pyroptosis Induced by Optic Nerve Crush

Role of PI3K/Akt and MEK/ERK in mediating hypoxia-induced expression of HIF-1alpha and VEGF in laser-induced rat choroidal neovascularization.

Role for NLRP3 inflammasome-mediated, Caspase1-dependent response in glaucomatous trabecular meshwork cell death and regulation of aqueous humor outflow

Long Non-Coding RNA-MALAT1 Mediates Retinal Ganglion Cell Apoptosis Through the PI3K/Akt Signaling Pathway in Rats with Glaucoma

CD82 Protects Against Glaucomatous Axonal Transport Deficits Via Mtorc1 Activation in Mice

Regulation of Angiogenin Expression and Epithelial-Mesenchymal Transition by HIF-1α Signaling in Hypoxic Retinal Pigment Epithelial Cells

Mammalian Target of Rapamycin Overexpression Antagonizes Chronic Hypoxia-Triggered Pulmonary Arterial Hypertension Via the Autophagic Pathway.

Involvement of Mglur I in EphB/ephrinB Reverse Signaling Activation Induced Retinal Ganglion Cell Apoptosis in a Rat Chronic Hypertension Model